Skip to content

Effect of anesthesia depth dual parameter (IoC) monitoring on the dosage of propofol and remifentanil in total intravenous anesthesia for patients undergoing knee arthroscopy

Effect of anesthesia depth dual parameter (IoC) monitoring on the dosage of propofol and remifentanil in total intravenous anesthesia for patients undergoing knee arthroscopy - Anesthesia depth dual parameter (IoC) monitoring

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086467
Enrollment
Unknown
Registered
2024-07-02
Start date
2022-12-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

17. Meniscus injury

Interventions

Contral :No dual parameter monitoring of anesthesia depth
Observation group:dual parameter monitoring of anesthesia depth:index of consciousness combined the injury sensitivity index(IoC)

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? Age >18 years old; ? American Society of anesthesiologists anesthesia classification I-II; ? Unilateral knee arthroscopic meniscus surgery; ? Body mass index (BMI) is 18 ~ 30kg / m2; ? The functions of heart, liver, kidney and lung are basically normal; No anemia; ? Knee arthroscopic meniscus surgery under total intravenous anesthesia; ? Complete case data.

Exclusion criteria

Exclusion criteria: ? Severe anemia; ? People who are allergic to opioids or propofol, remifentanil, etc; ? Have a history of acute and chronic respiratory system; ? Cardiovascular disease or mental disease; ? Organic dysfunction of heart, liver, kidney and lung; ? Abnormal hearing; ? Pregnant or lactating women; ? Bmi>30 kg / m2; ? Incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Dosage of propofol and remifentanil;Dual parameter monitoring of anesthesia depth;

Secondary

MeasureTime frame
Twelve cytokines expression;Perioperative vital signs;VAS;

Countries

China

Contacts

Public ContactFang Xie

Shanghai Sixth People's Hospital

fyyxz2015@163.com+86 158 2169 5291

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026